Liver Disease Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Liver Disease Diagnostics Market is Segmented by Diagnosis Technique (Liver Biopsy, Imaging Tests, Liver Function Tests, and Endoscopy), End User (Hospitals, Laboratories, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Liver Disease Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Liver Disease Diagnostics Industry Overview

The liver disease diagnostics market is fragmented in nature due to the presence of several companies operating globally as well as regionally and thus, it is moderately competitive. SOme of the key companies operating in the industry are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Randox Laboratories Ltd, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Siemens Healthcare GmbH, BioMerieux SA, Quest Diagnostics Incorporated, Biosino Bio-Technology and Science Inc, and Echosens.

Liver Disease Diagnostics Market Leaders

  1. F. Hoffmann-La Roche Ltd

  2. Echosens

  3. Siemens Healthcare GmbH

  4. Boston Scientific Corporation

  5. Thermo Fisher Scientific Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Picture1.png

Global Liver Disease Diagnostics Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?